Pfizer plans to spend $7.3 billion to acquire Metsera, making a strong return to the weight loss drug market.
```
After encountering setbacks in its own weight-loss drug development, Pfizer is repositioning itself through a major acquisition in hopes of carving out a share in this potentially $100 billion market.
According to media reports on the 22nd, Pfizer is close to reaching a deal to acquire weight-loss drug developer Metsera